廊坊發展(600149.SH):上半年淨利潤同比預增329%左右
格隆匯7月11日丨廊坊發展(600149.SH)公佈2025年半年度業績預增公吿,公司預計2025年半年度實現歸屬於母公司所有者的淨利潤為410萬元左右,與上年同期(法定披露數據)相比,將增加315萬元左右,同比增加329%左右;預計2025年半年度實現歸屬於母公司所有者的扣除非經常性損益的淨利潤為400萬元左右,與上年同期(法定披露數據)相比,將增加358萬元左右,同比增加855%左右。
2025年上半年實現業績預增的主要原因是:供熱業務所需主要燃料煤炭單價較上年同期有所下降,以及財務費用、折舊費用較上年同期有所減少。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.